RELATED CONTENT
August 12, 2020 — As healthcare providers and essential personnel work on the front lines of the COVID-19 pandemic, the ...
August 12, 2020 
June 5, 2020 — The following speech was delivered by Stephen M. Hahn, M.D., Commissioner of Food and Drugs - Food and ...
June 05, 2020 
April 24, 2020 — The Food and Drug Administration (FDA or the Agency) plays a critical role in protecting the United ...
April 24, 2020 
March 25, 2020 — According to a statement on March 24 from Commissioner of Food and Drugs - Food and Drug Administration ...
March 25, 2020 
March 2, 2020 — As part of the U.S. Food and Drug Administration’s ongoing and aggressive commitment to address the ...
March 02, 2020 
February 16, 2020 — The following statement was issued by the U.S. Food and Drug Administration (FDA) on February 14 ...
February 16, 2020 
November 22, 2019 — In September, the Food and Drug Administration (FDA) issued draft guidance titled “Safer ...
November 22, 2019 
The U.S. Food and Drug Administration (FDA) announced it is building the foundations of a national evaluation system to generate better evidence more efficiently for medical device evaluation and regulatory decision-making. The agency said a national evaluation system would generate evidence across the total product lifecycle of medical devices by strategically and systematically leveraging real-world evidence, and applying advanced analytics to data tailored to the unique data needs and innovation cycles of medical devices.
February 01, 2017 
The U.S. Food and Drug Administration (FDA) is alerting patients who had mammograms at Coastal Diagnostic Center in Pismo Beach, California, on or after Feb. 24, 2013, about possible problems with the quality of their mammograms. This does not mean that the results of the mammograms were inaccurate, but it does mean that the patients should consider having their mammograms re-evaluated at a Mammography Quality Standards Act (MQSA)-certified facility to determine if they need a repeat mammogram or additional medical follow-up.
April 30, 2015 The U.S. Food and Drug Administration (FDA) reports that it has reached an agreement with Lancaster Breast Imaging of Lancaster, Pennsylvania, in regards to a Mammography Quality Standards Act (MQSA) violation self-reported by the facility. Lancaster Breast Imaging is still performing mammography to date.
April 24, 2015